Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000820253 | SCV000960959 | benign | Tuberous sclerosis 2 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001020564 | SCV001182060 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-05-08 | criteria provided, single submitter | clinical testing | The p.T1181M variant (also known as c.3542C>T), located in coding exon 29 of the TSC2 gene, results from a C to T substitution at nucleotide position 3542. The threonine at codon 1181 is replaced by methionine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Johns Hopkins Genomics, |
RCV000820253 | SCV001438386 | uncertain significance | Tuberous sclerosis 2 | 2020-09-14 | criteria provided, single submitter | clinical testing | This TSC2 variant (rs373481458) is rare (<0.1%) in a large population dataset (gnomAD: 5/282382 total alleles; 0.002%; no homozygotes) and has an entry in ClinVar. Two bioinformatics tools queried predict that this substitution would be tolerated, while another predicts it would be damaging. The threonine residue at this position is conserved across most mammalian species assessed. This variant is not predicted to affect normal exon 30 splicing, although this has not been confirmed experimentally to our knowledge. Due to insufficient evidence, we consider the clinical significance of c.3542C>T to be uncertain at this time. |
Genome- |
RCV000820253 | SCV002040783 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001020564 | SCV002533418 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-11-02 | criteria provided, single submitter | curation | |
ITMI | RCV000122224 | SCV000086445 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |